Eagle Capital Management (New York)’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$702K Sell
10,970
-1,086
-9% -$71.4K ﹤0.01% 53
2026
Q1
$858K Hold
12,056
﹤0.01% 55
2025
Q4
$989K Sell
12,056
-79
-0.7% -$6.16K ﹤0.01% 54
2025
Q3
$911K Hold
12,135
﹤0.01% 51
2025
Q2
$899K Hold
12,135
﹤0.01% 50
2025
Q1
$979K Sell
12,135
-4,631
-28% -$398K ﹤0.01% 50
2024
Q4
$1.31M Hold
16,766
﹤0.01% 44
2024
Q3
$1.57M Sell
16,766
-2,500
-13% -$210K 0.01% 41
2024
Q2
$1.5M Hold
19,266
0.01% 41
2024
Q1
$1.75M Hold
19,266
0.01% 39
2023
Q4
$1.49M Hold
19,266
0.01% 40
2023
Q3
$1.31M Sell
19,266
-2,022
-9% -$147K 0.01% 36
2023
Q2
$1.73M Sell
21,288
-1,627
-7% -$130K 0.01% 36
2023
Q1
$1.88M Buy
+22,915
New +$1.64M 0.01% 36

Other funds holding GEHC

Eagle Capital Management (New York)'s GEHC Position: Q2 2026 in Review

Eagle Capital Management (New York) reduced its GE HealthCare (GEHC) stake by 9% in Q2 2026, selling an estimated $71.4K and leaving 10,970 shares worth $702K. The position accounts for ﹤0.01% of the portfolio, ranked #53.

Eagle Capital Management (New York) first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.88M in Q1 2023. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Eagle Capital Management (New York) held 10,970 shares of GE HealthCare worth $702K as of Q2 2026.
  • Eagle Capital Management (New York) sold 1,086 GE HealthCare shares in Q2 2026, an estimated $71.4K.
  • GE HealthCare made up ﹤0.01% of Eagle Capital Management (New York)'s portfolio in Q2 2026, its #53 holding.
  • Eagle Capital Management (New York) first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Eagle Capital Management (New York)'s GE HealthCare position peaked at $1.88M in Q1 2023.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Eagle Capital Management (New York)'s 13F filing for Q2 2026, filed 14 Aug 2026.